Safety and efficacy of maintenance ketamine treatment in patients with treatment-refractory generalised anxiety and social anxiety disorders.
Journal of Psychopharmacology June 2018 Paul Glue, Shona Neehoff, Natalie J. Medlicott et al.
In this maintenance treatment study, we sought to evaluate the effect on anxiety ratings, safety and tolerability of 3 months of weekly ketamine in 20 patients with treatment-refractory DSM IV generalised anxiety disorder (GAD) and/or social anxiety disorder (SAD), and subsequent assessment of remission post-treatment. This was an uncontrolled open-label study in 20 patients who had been...
DOI: 10.1177/0269881118762073 (opens in new tab)
Full text (opens in new tab)
Ketamine
Generalised anxiety disorder
Maintenance treatment
Social anxiety disorder